rs878855173
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_033118.4(MYLK2):c.1265T>C(p.Val422Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,606,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033118.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.1265T>C | p.Val422Ala | missense_variant | Exon 9 of 13 | 1 | NM_033118.4 | ENSP00000365152.4 | ||
MYLK2 | ENST00000375994.6 | c.1265T>C | p.Val422Ala | missense_variant | Exon 8 of 12 | 1 | ENSP00000365162.2 | |||
MYLK2 | ENST00000468730.1 | n.203T>C | non_coding_transcript_exon_variant | Exon 2 of 6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000138 AC: 2AN: 144724Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251344 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461842Hom.: 0 Cov.: 39 AF XY: 0.00 AC XY: 0AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000138 AC: 2AN: 144724Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 69748 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance but additional evidence is not available (ClinVar Variant ID# 241741; Landrum et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect -
Hypertrophic cardiomyopathy 1 Uncertain:1
This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a MYLK2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This sequence change replaces valine with alanine at codon 422 of the MYLK2 protein (p.Val422Ala). The valine residue is highly conserved and there is a small physicochemical difference between valine and alanine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at